About Cofactor Genomics
Cofactor Genomics is a Healthcare company based in San Francisco (United States) founded in 2009. Diagnostic assays are developed using RNA sequencing technology. Cofactor Genomics has raised $26.2 million across 7 funding rounds from investors including Leland Stanford Junior University, Wilson Sonsini Goodrich & Rosati and HHS. The company has 9 employees. Cofactor Genomics has completed 1 acquisition, including Narus Biotechnologies. Cofactor Genomics offers products and services including OncoPrism and ImmunoPrism. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics. Its legal entity is COFACTOR GENOMICS, INC. Its competitors include Veracyte, Cajal Neuroscience and Alida Biosciences; 3 of its 3 listed competitors have raised funding.
Company details
Developer of diagnostic assays using RNA sequencing. The companys product includes ImmunoPrism is an RNA sequencing-based assay that uses predictive immune modeling to generate multidimensional biomarkers. It combines machine learning and RNA-sequencing to build gene expression models for immune cells. The companys models for key immune cells include Immune Health Expression Models, Immune Escape Genes, and Co-inhibitory molecules. The companys sequencing products include mRNAble, Total RNAble, picoRNA, FFPExact, miRNAble, RNAccess, RNAmplify, and RNAdvantage.
- Headquarters San Francisco, United States
- Employees 9
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website cofactorgenomics.com
- Social LinkedIn X Facebook
- Legal Name Cofactor Genomics, Inc.
- Total Equity Funding$26.2M (USD)
in 7 rounds
- InvestorsLeland Stanford Junior University
& 9 more
- Employee Count9
- Investments & Acquisitions
Products & Services of Cofactor Genomics
Cofactor Genomics offers a comprehensive portfolio of products and services, including OncoPrism and ImmunoPrism.
Predicts patient response to cancer immunotherapy via RNA analysis
Assesses immune responses for clinical research and diagnostics
Funding Insights of Cofactor Genomics
Cofactor Genomics has successfully raised a total of $26.2M across 7 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $26.2M
- Total Rounds 7
- First Round $1.57M
(Sep 2014)
- Investors Count 10
All 7 funding rounds of Cofactor Genomics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2025 | Series B | – | – | ||
| Aug 2023 | $1.17M | Series A | – | – | – |
| Dec 2021 | $6.91M | Series A | – | – | – |
| Jun 2017 | $18M | Series A | – | Menlo Ventures | |
| Sep 2015 | Seed | – | 7percent Ventures | – | |
| Jun 2015 | $120,000 | Seed | – | Y Combinator | – |
| Sep 2014 | $1.57M | Grant | – | – |
10 investors in total: 10 institutional.
Investors in Cofactor Genomics
Cofactor Genomics has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Leland Stanford Junior University, Wilson Sonsini Goodrich & Rosati and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage venture capital firm investing in AI, healthcare, and tech sectors. | menlovc.com | |||
Venture capital firm focused on multiple sectors | dcvc.com | Palo Alto, United States | ||
Strategic investments in healthcare technologies and data innovations. | ascensionventures.org | |||
Early-stage startups are accelerated via funding and educational programs. | ycombinator.com | Mountain View, United States | ||
Early-stage investments are targeted by iSelect Fund in key sectors. | iselectfund.com | St. Louis, United States | ||
Provider of legal services to technology and life science companies | 1961 | wsgr.com | Palo Alto, United States | |
Various courses and degrees across diversified streams are offered. | 1876 | stanford.edu | United States | |
Early-stage venture capital investments are made in innovative startups. | 7pc.co | London, England | ||
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Provider of laboratory tests for physicians | labcorp.com |
Investor details for Cofactor Genomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cofactor Genomics
2 people are tracked at Cofactor Genomics (2 in leadership); the tracked headcount is 9.
| Name | Role | Group |
|---|---|---|
Jarret Glasscock | CTO | Leadership |
Eric Duncavage | Medical Director | Leadership |
Complete people profiles for Cofactor Genomics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cofactor Genomics
Cofactor Genomics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Narus Biotechnologies.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
RNA-based diagnostic tests for neurological disorders are developed. | narusbio.com | San Francisco, United States | 2015 | Feb 2016 | •••• |
Complete acquisition details for Cofactor Genomics
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Cofactor Genomics
4 dated milestones of Cofactor Genomics across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Cofactor Genomics is founded.
- Funding First funding round of $1.6M.
- Acquisition Acquires Narus Biotechnologies.
- Funding Latest funding round, Series B,.
Competitors of Cofactor Genomics
Cofactor Genomics has 3 listed competitors in our database, 3 of them funded. They include Veracyte, Cajal Neuroscience and Alida Biosciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| veracyte.com | 2008 | San Francisco, United States | $67.9M | 815 | Genomics-based diagnostic tests for cancer are developed. | |
| cajalneuro.com | 2020 | Seattle, United States | $96M | Neurodegenerative disease drugs are developed through genetic screening and multi-omics. | ||
| alidabio.com | 2020 | San Diego, United States | $11.52M | 17 | Technology for RNA analysis is provided to advance human health. |
Detailed competitors of Cofactor Genomics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cofactor Genomics
The website of Cofactor Genomics (cofactorgenomics.com) receives about 4.2K visits a month.
- Monthly visits4.2K
▲ 42.4% vs previous month
Websites whose visitors overlap most with Cofactor Genomics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
expressionanalysis.com | expressionanalysis.com | 100% | – | ||
entelechon.com | entelechon.com | 91% | – | ||
| altogenlabs.com | 83% | 14K | #1,800,688 | View details | |
| lark.com | 78% | 134.7K | #279,462 | View details | |
| exonbio.com | 76% | 4K | #4,969,058 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 25 similar websites and full traffic analytics for Cofactor Genomics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 25 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Cofactor Genomics (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cofactor Genomics
Complete news archive for Cofactor Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cofactor Genomics
Cofactor Genomics was founded in 2009 and raised its 1st funding round 5 years after it was founded.
Cofactor Genomics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Cofactor Genomics is a funded company, having raised a total of $26.2M across 7 funding rounds to date. The company's 1st funding round was a Grant of $1.57M, raised on Sep 2014.
Cofactor Genomics has 9 employees.
Developer of diagnostic assays using RNA sequencing. The companys product includes ImmunoPrism is an RNA sequencing-based assay that uses predictive immune modeling to generate multidimensional biomarkers. It combines machine learning and RNA-sequencing to build gene expression models for immune cells. The companys models for key immune cells include Immune Health Expression Models, Immune Escape Genes, and Co-inhibitory molecules. The companys sequencing products include mRNAble, Total RNAble, picoRNA, FFPExact, miRNAble, RNAccess, RNAmplify, and RNAdvantage.
Cofactor Genomics's top competitors include Veracyte, Alida Biosciences and Cajal Neuroscience.
Cofactor Genomics offers OncoPrism and ImmunoPrism.
Cofactor Genomics has made 1 acquisition, including Narus Biotechnologies.
Cofactor Genomics has 10 investors. Key investors include Leland Stanford Junior University, Wilson Sonsini Goodrich & Rosati, HHS, Menlo Ventures, and DCVC.
Cofactor Genomics operates through Cofactor Genomics, Inc..